基本信息
浏览量:18
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Dr. Matthias E Lauer is Senior Principal Scientist at F. Hoffmann - La Roche Ltd. and supports the drug discovery unit of the Pharma Research Division. He established the cryo EM facility and the nanoscience laboratory of the Roche Innovation Center Basel.
As a physical chemist his thesis dedicated the synthesis and physical characterization of light harvesting supramolecular porphyrin assemblies with Prof. Dr. Jurgen-Hinrich Fuhrhop at the Free University of Berlin, Germany. As a DFG Postdoc he joined the group of Prof. Dr. Helen and Prof. Dr. Paul Hansma at the Physics Department of the University of California Santa Barbara, United States. At the Biozentrum of the University Basel Switzerland and with Prof. Dr. Andreas Engel, he established applications of cryo-TEM and AFM in drug discovery and pharmaceutical research, to join Roche in 2010.
Since, he supports teams focused on drug and biomarker discovery with a focus on neurodegenerative diseases. In this role, he initiated and moved an outstanding imaging study, which dedicated the visualization of Lewy Pathology in Parkinson Disease on the nanoscale. Human brains with short post mortem delay were analyzed with complementary imaging methods, the results were published in 2019 and have transformative impact.
Over the years, many innovative methods were moved into lab routines, they enable to analyze the particle structures and properties, which guide drug discovery and pharmaceutical research in industry, on the level of single particles.
- Structure determination of drug target interactions with high-resolution cryo EM.
- Time resolved AFM to monitor the action of antibody architectures and conformational changes in complex with disease related targets.
- High-resolution imaging of therapeutic proteins to predict the risk of side product formation in early discovery phases.
- Structure and behavior of viral capsids and lipid nanoparticles to enable the delivery of genes and RNAs in early and late phases.
- Scanning Probe Microscopy to monitor the molecular mobility in solid dosage forms and to predict shelf life stability within hours instead of month.
- Nanoindentation testing to predict the risk of mechanical failure in late stage technical processes.
Currently, he is collaborating with innovative partners in academia and industry to enable the discovery of next generation medicines.
研究兴趣
论文共 51 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Eric-André Kusznir, Jean-Christophe Hau, Michaela Portmann, Anne-Gaëlle Reinhart, Fabio Falivene, Jessica Bastien,Jesper Worm,Alfred Ross,Matthias Lauer,Philippe Ringler,Filippo Sladojevich,Sylwia Huber,
Bioconjugate chemistryno. 5 (2023): 866-879
Anna Pratsinis,Yuchen Fan, Michaela Portmann,Michal Hammel,Ponien Kou,Apoorva Sarode,Philippe Ringler, Lubomir Kovacik,Matthias E Lauer,Jens Lamerz,Greg L Hura,Chun-Wan Yen,
Anne-Gaelle Reinhart,Anja Osterwald,Philippe Ringler, Yael Leiser,Matthias E. Lauer,Rainer E. Martin,Christoph Ullmer,Felix Schumacher,Claudia Korn,Michael Keller
MOLECULAR PHARMACEUTICSno. 12 (2023): 6492-6503
Luca Rima, Michael Zimmermann, Andri Fraenkl, Thomas Clairfeuille,Matthias Lauer,Andreas Engel,Hans-Andreas Engel,Thomas Braun
FARADAY DISCUSSIONSno. 0 (2022): 55-66
Philip Grossen, Michaela Portmann,Erich Koller,Martina Duschmalé,Tanja Minz,Sabine Sewing,Nikhil Janak Pandya,Sabine Kux van Geijtenbeek,Axel Ducret, Eric-André Kusznir,Sylwia Huber,Marco Berrera,
加载更多
作者统计
#Papers: 51
#Citation: 2637
H-Index: 23
G-Index: 43
Sociability: 6
Diversity: 3
Activity: 16
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn